RYTM - Rhythm Pharmaceuticals Inc.
IEX Last Trade
47.39
1.290 2.722%
Share volume: 247,081
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$46.10
1.29
2.80%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-03 | 2022-11-08 | 2023-03-01 | 2023-05-02 | 2023-08-01 | 2023-11-08 | 2024-02-29 | 2024-05-07 | |
| Total revenue | 9.066 M | 4.284 M | 8.790 M | 11.469 M | 19.221 M | 22.504 M | 24.234 M | 25.967 M | |
| Cost of revenue | 378.000 K | 497.000 K | 1.028 M | 1.421 M | 2.236 M | 2.412 M | 3.233 M | 2.807 M | |
| Gross profit | 8.688 M | 3.787 M | 7.762 M | 10.048 M | 16.985 M | 20.092 M | 21.001 M | 23.160 M | |
| -56.41% | 104.96% | 29.45% | 69.04% | 18.29% | 4.52% | 10.28% | |||
| Operating expenses | 53.784 M | 43.054 M | 49.865 M | 62.579 M | 63.589 M | 64.045 M | 62.270 M | 163.047 M | |
| Selling general and admin | 22.328 M | 21.938 M | 26.317 M | 24.634 M | 30.046 M | 30.475 M | 32.377 M | 34.382 M | |
| Research and development | 31.456 M | 21.116 M | 23.548 M | 37.945 M | 33.543 M | 33.570 M | 29.893 M | 128.665 M | |
| Total expenses | 54.162 M | 43.551 M | 50.893 M | 64.000 M | 65.825 M | 66.457 M | 65.503 M | 165.854 M | |
| -19.59% | 16.86% | 25.75% | 2.85% | 0.96% | -1.44% | 153.20% | |||
| Operating income | -45.096 M | -39.267 M | -42.103 M | -52.531 M | -46.604 M | -43.953 M | -41.269 M | -139.887 M | |
| Ebit | -45.096 M | -39.267 M | -42.103 M | -52.531 M | -46.604 M | -43.953 M | -41.269 M | -139.887 M | |
| Pretax income | -45.001 M | -40.861 M | -42.493 M | -52.179 M | -46.703 M | -43.795 M | -41.437 M | -141.072 M | |
| -9.20% | 3.99% | 22.79% | -10.49% | -6.23% | -5.38% | 240.45% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 368.000 K | 196.000 K | 300.000 K | |
| Net income basic | -45.001 M | -40.861 M | -42.493 M | -52.179 M | -46.703 M | -44.163 M | -41.633 M | -141.372 M | |
| 9.20% | -3.99% | -22.79% | 10.49% | 5.44% | 5.73% | -239.57% | |||
| Net income | -45.001 M | -40.861 M | -42.493 M | -52.179 M | -46.703 M | -44.163 M | -41.633 M | -141.372 M | |
| 9.20% | -3.99% | -22.79% | 10.49% | 5.44% | 5.73% | -239.57% |